Prenetics

Prenetics is an innovative biotechnology company based in Hong Kong that is committed to precision medicine. Its self-developed iGenes pharmacogenomics test collects oral cell samples from patients to predict drug responses based on individual genetic differences, helping doctors prescribe the most appropriate medications and dosages for patients. Prenetics, which operates in 10 countries/regions, launched a program called Project Screen under the name Circle, aiming to make COVID-19 testing simple, safe, and accurate. The company plans to introduce a rapid SARS-CoV-2 nucleic acid test in the fourth quarter of 2020, which will deliver results within 15 to 30 minutes. This test is highly scalable, low-cost, does not require a laboratory, and allows for frequent testing.